[Prognostic factors analysis for R-CHOP regimen therapy in diffuse large B cell lymphoma].

Yang Shen, Yu Yao, Junmin Li, Qiusheng Chen, Jianhua You, Huijin Zhao, Shu Chen, Zhixiang ShenPubMed 2008

Abstract

IPI score has its limitation in predicting the prognosis in the R-CHOP era in DLBCL. Other two relevant prognostic factors are bulky disease and achieved CR after 6 courses of treatment.
BibTeX
@inproceedings{shen2008prognostic,
  author = {Yang Shen and Yu Yao and Junmin Li and Qiusheng Chen and Jianhua You and Huijin Zhao and Shu Chen and Zhixiang Shen},
  title = {{[Prognostic factors analysis for R-CHOP regimen therapy in diffuse large B cell lymphoma].}},
  booktitle = {PubMed},
  year = {2008},
}

Loading related content...

Figure